SPTBN2 and metastatic malignant neoplasm in the lymph nodes: What’s more, SPTBN2 was associated with poor prognosis in patients with colorectal cancer and was highly expressed in patients with distant metastasis, lymph node metastasis, and clinical advanced colorectal cancer, with statistically significant differences [8].